开云app官网登录入口网页版-官方正版

#达肝素#

7篇内容 | 916人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1747685, encodeId=d15c1e47685ae, content=<a href='/topic/show?id=73fe93955ff' target=_blank style='color:#2F92EE;'>#达肝素#</a>, objectTitle=NEJM：阿哌沙班在治疗癌症相关VTE方面不逊于达肝素（Caravaggio研究）, objectType=article, longId=191548, objectId=74d219154804, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74d219154804, replyNumber=0, likeNumber=67, createdTime=2021-02-24, rootId=0, userName=xlysu, userId=edf435938443, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74d219154804, moduleTitle=NEJM：阿哌沙班在治疗癌症相关VTE方面不逊于达肝素（Caravaggio研究）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=74d219154804)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1747684, encodeId=95f21e4768478, content=<a href='/topic/show?id=73fe93955ff' target=_blank style='color:#2F92EE;'>#达肝素#</a>, objectTitle=J Thromb Haemost：阿哌沙班和达肝素在活动性恶性肿瘤相关的静脉血栓栓塞中的疗效, objectType=article, longId=181698, objectId=611d181698e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=611d181698e9, replyNumber=0, likeNumber=59, createdTime=2020-04-08, rootId=0, userName=xlysu, userId=edf435938443, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=611d181698e9, moduleTitle=J Thromb Haemost：阿哌沙班和达肝素在活动性恶性肿瘤相关的静脉血栓栓塞中的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=611d181698e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1747683, encodeId=c1271e47683d9, content=<a href='/topic/show?id=73fe93955ff' target=_blank style='color:#2F92EE;'>#达肝素#</a>, objectTitle=儿童抗凝药获批！美FDA批准达肝素钠注射剂用于儿童, objectType=article, longId=166580, objectId=8eee16658030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eee16658030, replyNumber=0, likeNumber=66, createdTime=2019-09-26, rootId=0, userName=xlysu, userId=edf435938443, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eee16658030, moduleTitle=儿童抗凝药获批！美FDA批准达肝素钠注射剂用于儿童, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8eee16658030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1747681, encodeId=75b71e47681ad, content=<a href='/topic/show?id=73fe93955ff' target=_blank style='color:#2F92EE;'>#达肝素#</a>, objectTitle=JAHA：磺达肝素钠与低分子量肝素在围手术期血栓预防的疗效比较, objectType=article, longId=166177, objectId=ae1a1661e713, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae1a1661e713, replyNumber=0, likeNumber=62, createdTime=2019-06-15, rootId=0, userName=xlysu, userId=edf435938443, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae1a1661e713, moduleTitle=JAHA：磺达肝素钠与低分子量肝素在围手术期血栓预防的疗效比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ae1a1661e713)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1747682, encodeId=c9051e47682d1, content=<a href='/topic/show?id=73fe93955ff' target=_blank style='color:#2F92EE;'>#达肝素#</a>, objectTitle=FDA批准Fragmin（达肝素钠）作为儿童的第一个抗凝剂, objectType=article, longId=166317, objectId=d5d816631e72, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5d816631e72, replyNumber=0, likeNumber=59, createdTime=2019-08-21, rootId=0, userName=xlysu, userId=edf435938443, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5d816631e72, moduleTitle=FDA批准Fragmin（达肝素钠）作为儿童的第一个抗凝剂, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d5d816631e72)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1747680, encodeId=83be1e47680a2, content=<a href='/topic/show?id=73fe93955ff' target=_blank style='color:#2F92EE;'>#达肝素#</a>, objectTitle=Chest：创伤患者血栓预防：达肝素vs依诺肝素, objectType=article, longId=116837, objectId=b78f11683e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b78f11683e2a, replyNumber=0, likeNumber=54, createdTime=2018-06-24, rootId=0, userName=xlysu, userId=edf435938443, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b78f11683e2a, moduleTitle=Chest：创伤患者血栓预防：达肝素vs依诺肝素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b78f11683e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1747679, encodeId=6bb41e476796c, content=<a href='/topic/show?id=73fe93955ff' target=_blank style='color:#2F92EE;'>#达肝素#</a>, objectTitle=Chest：依诺肝素和达肝素在创伤后血栓预防中的疗效比较！, objectType=article, longId=109200, objectId=8eaa109200e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eaa109200e9, replyNumber=0, likeNumber=75, createdTime=2018-06-01, rootId=0, userName=xlysu, userId=edf435938443, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eaa109200e9, moduleTitle=Chest：依诺肝素和达肝素在创伤后血栓预防中的疗效比较！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8eaa109200e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

达肝素

2020-05-29

xlysu (审核中...)

前往app查看评论内容

#达肝素#

NEJM：阿哌沙班在治疗癌症相关VTE方面不逊于达肝素（Caravaggio研究）

2021-02-24

xlysu (审核中...)

前往app查看评论内容

#达肝素#

J Thromb Haemost：阿哌沙班和达肝素在活动性恶性肿瘤相关的静脉血栓栓塞中的疗效

2020-04-08

xlysu (审核中...)

前往app查看评论内容

#达肝素#

儿童抗凝药获批！美FDA批准达肝素钠注射剂用于儿童

2019-09-26

xlysu (审核中...)

前往app查看评论内容

#达肝素#

JAHA：磺达肝素钠与低分子量肝素在围手术期血栓预防的疗效比较

2019-06-15

xlysu (审核中...)

前往app查看评论内容

#达肝素#

FDA批准Fragmin（达肝素钠）作为儿童的第一个抗凝剂

2019-08-21

xlysu (审核中...)

前往app查看评论内容

#达肝素#

Chest：创伤患者血栓预防：达肝素vs依诺肝素

2018-06-24

xlysu (审核中...)

前往app查看评论内容

#达肝素#

Chest：依诺肝素和达肝素在创伤后血栓预防中的疗效比较！

2018-06-01

科室
- - 订阅+
  - 更多科室
工具
服务